Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply-Reference-Cited by-同舟云学术

Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply

Published:2023-04-24 Issue:10 Volume:57 Page:1163-1165
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hirano Ikuo¹^ORCID,Dellon Evan S.²,Gupta Sandeep K.³⁴,Katzka David A.⁵^ORCID,Collins Margaret H.⁶,Wojtowicz Abigail M.⁷,Terreri Brian⁷,Zhang Wenwen⁸,Boules Mena⁷,Bhatia Siddharth⁹,Desai Nirav K.⁸

Affiliation:

1. Division of Gastroenterology and Hepatology Northwestern University Feinberg School of Medicine Chicago Illinois USA

2. Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

3. Section of Pediatric Gastroenterology, Hepatology and Nutrition, Indiana University School of Medicine Riley Hospital for Children at Indiana University Health Indianapolis Indiana USA

4. Community Health Network Indianapolis Indiana USA

5. Division of Gastroenterology Columbia University Medical Center New York New York USA

6. Department of Pathology and Laboratory Medicine Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine Cincinnati Ohio USA

7. Takeda Pharmaceuticals USA, Inc. Lexington Massachusetts USA

8. Takeda Development Center Americas, Inc. Cambridge Massachusetts USA

9. Takeda Pharmaceuticals International Co. Cambridge Massachusetts USA

Abstract

LINKED CONTENTThis article is linked to Hirano et al papers. To view these articles, visit https://doi.org/10.1111/apt.17430 and https://doi.org/10.1111/apt.17442.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17476

Reference10 articles.

1. Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis–new data bring new questions

2. Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials

3. Herpes Simplex Virus Esophagitis in Immunocompetent Children: A Harbinger of Eosinophilic Esophagitis?

4. A patient with eosinophilic esophagitis and herpes simplex esophagitis: a case report and literature review;Marella HK;Case Rep Gastrointest Med,2021

5. AGA Institute and the joint task force on allergy‐immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis;Hirano I;Gastroenterology,2020